Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions.

Leukocyte infiltration is a hallmark of inflammation. Knowledge on molecular mechanisms of leukocyte infiltration has advanced rapidly due to the recent elucidation of structures and functions of adhesion molecules and chemokines. Since the discovery of interleukin-8 (IL-8), a prototype of CXC chemokines, in 1987 and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 (MCAF/MCP-1), a prototype of chemotactic cytokines (CC) chemokines, in 1989, more than 30 members of chemokines have been identified so far. Evidence is accumulating that these chemokines exert overlapping but distinct actions on specific types of leukocytes in vitro through interacting with their specific G-protein-coupled receptors with seven transmembrane domains. However, redundancy at receptor levels has frequently hindered the clarification on the precise physiological or pathophysiological roles of chemokines. Here, we describe the pathophysiological roles of IL-8 and MCAF/MCP-1 in several animal models of neutrophil- and macrophage-mediated inflammation, respectively, by focusing on our recent work using neutralizing antibodies to these chemokines. We discuss further potential roles of these chemokines in T-lymphocyte-mediated immune responses.

[1]  M. Peitsch,et al.  The chemokine information source: identification and characterization of novel chemokines using the WorldWideWeb and Expressed Sequence Tag Databases , 1997, Journal of leukocyte biology.

[2]  C. Mackay,et al.  Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion. , 1997, Circulation.

[3]  P. Dorinsky,et al.  Acid aspiration-induced acute lung injury causes leukocyte-dependent systemic organ injury. , 1993, Journal of applied physiology.

[4]  N. Simonian,et al.  Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage. , 1996, Stroke.

[5]  K. Matsushima,et al.  Detection of urinary interleukin-8 in glomerular diseases. , 1994, Kidney international.

[6]  R. Strieter,et al.  An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. , 1995, Journal of immunology.

[7]  Armen B. Shanafelt,et al.  The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*) , 1995, The Journal of Biological Chemistry.

[8]  J. Schröder,et al.  Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. , 1987, Journal of immunology.

[9]  F. Balkwill,et al.  The cytokine network. , 1989, Immunology today.

[10]  G. Opdenakker,et al.  Human monocyte chemotactic protein-3 (MCP-3): molecular cloning of the cDNA and comparison with other chemokines. , 1993, Biochemical and biophysical research communications.

[11]  H. Broxmeyer,et al.  Involvement of Interleukin (IL) 8 receptor in negative regulation of myeloid progenitor cells in vivo: evidence from mice lacking the murine IL-8 receptor homologue , 1996, The Journal of experimental medicine.

[12]  H. Mikawa,et al.  Interleukin 8 (IL-8) selectively inhibits immunoglobulin E production induced by IL-4 in human B cells , 1992, The Journal of experimental medicine.

[13]  D. Schadendorf,et al.  IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. , 1993, Journal of immunology.

[14]  M. Reale,et al.  Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. , 1997, Journal of vascular research.

[15]  R. Bravo,et al.  Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. , 1995, Journal of immunology.

[16]  J. Hogg Neutrophil kinetics and lung injury. , 1987, Physiological reviews.

[17]  B. Rollins,et al.  Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[18]  B. Rovin,et al.  Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[19]  P. Allavena,et al.  Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. , 1995, Journal of immunology.

[20]  W. Karpus,et al.  Differential CC chemokine-induced enhancement of T helper cell cytokine production. , 1997, Journal of immunology.

[21]  B. Bell,et al.  CBF and time thresholds for the formation of ischemic cerebral edema, and effect of reperfusion in baboons. , 1985, Journal of neurosurgery.

[22]  B. Rollins,et al.  Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. , 1991, Blood.

[23]  J. McCord,et al.  Superoxide radicals in feline intestinal ischemia. , 1981, Gastroenterology.

[24]  David J. Smith,et al.  Ischemia-reperfusion in humans. Appearance of xanthine oxidase activity. , 1990, The American journal of pathology.

[25]  J. Hoeffel,et al.  Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. , 1994, Journal of immunology.

[26]  M. Matthay,et al.  Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. , 1992, The American review of respiratory disease.

[27]  T. Schall,et al.  Proton NMR assignments and solution conformation of RANTES, a chemokine of the C-C type. , 1995, Biochemistry.

[28]  T. Williams,et al.  Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8. , 1995, The Journal of clinical investigation.

[29]  W. Wood,et al.  Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. , 1994, Science.

[30]  T. Schall,et al.  C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. Role for G proteins. , 1994, Journal of immunology.

[31]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[32]  M. Baggiolini,et al.  Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release. , 1996, Journal of immunology.

[33]  N. Mukaida,et al.  Prevention of endotoxin-induced acute lethality in Propionibacterium acnes-primed rabbits by an antibody to leukocyte integrin beta 2 with concomitant reduction of cytokine production , 1995, Infection and immunity.

[34]  T. Brunner,et al.  Monocyte chemotactic protein 1 is a potent activator of human basophils , 1992, The Journal of experimental medicine.

[35]  E. Appella,et al.  Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[36]  E. Connolly,et al.  Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. , 1996, The Journal of clinical investigation.

[37]  M. Baggiolini,et al.  Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils , 1990, The Journal of experimental medicine.

[38]  K. Matsushima,et al.  Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). , 1987, Journal of immunology.

[39]  M. Lamm,et al.  IgA nephropathy: perspectives on pathogenesis and classification. , 1985, Clinical nephrology.

[40]  L. Williams,et al.  Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. , 1997, Journal of immunology.

[41]  B. Dewald,et al.  Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. , 1994, Advances in immunology.

[42]  Virginia Litwin,et al.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.

[43]  E. Appella,et al.  Human monocyte chemoattractant protein‐1 (MCP‐1) Full‐length cDNA cloning, expression in mitogen‐stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE , 1989, FEBS letters.

[44]  R. Strieter,et al.  Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups , 1993, The Lancet.

[45]  R. Whyte,et al.  Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma , 1994, The Journal of experimental medicine.

[46]  C. Valeri,et al.  Synergism between leukotriene B4 and thromboxane A2 in mediating acid-aspiration injury. , 1992, Surgery.

[47]  K. Matsushima,et al.  Inhibition of IL-8-induced W3/25+ (CD4+) T lymphocyte recruitment into subcutaneous tissues of rats by selective depletion of in vivo neutrophils with a monoclonal antibody. , 1991, Journal of immunology.

[48]  E. Appella,et al.  Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line , 1990, The Journal of experimental medicine.

[49]  D. S. Garrett,et al.  High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR. , 1994, Science.

[50]  B. Rollins,et al.  High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. , 1995, Journal of immunology.

[51]  Koichiro Nakamura,et al.  Keratinocyte-derived monocyte chemoattractant protein 1 (MCP-1): analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin. , 1995, The Journal of investigative dermatology.

[52]  A. Huber,et al.  Regulation of transendothelial neutrophil migration by endogenous interleukin-8. , 1991, Science.

[53]  McCord Jm Oxygen-derived radicals: a link between reperfusion injury and inflammation. , 1987 .

[54]  K. Matsushima,et al.  Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP‐1) , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[55]  C. Valeri,et al.  A Mac-1 antibody reduces liver and lung injury but not neutrophil sequestration after intestinal ischemia-reperfusion. , 1992, Surgery.

[56]  K. Matsushima,et al.  Expression of recombinant rabbit IL-8 in Escherichia coli and establishment of the essential involvement of IL-8 in recruiting neutrophils into lipopolysaccharide-induced inflammatory site of rabbit skin. , 1993, International immunology.

[57]  P. Murphy The molecular biology of leukocyte chemoattractant receptors. , 1994, Annual review of immunology.

[58]  Yun Xing,et al.  Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate ( , 1993, The Journal of clinical investigation.

[59]  T. Murayama,et al.  [Molecular mechanism of interleukin-8 gene expression]. , 1994, Rinsho byori. The Japanese journal of clinical pathology.

[60]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[61]  T. Yue,et al.  Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex. , 1995, Stroke.

[62]  B. Rollins,et al.  Biochemical and biologic characterization of murine monocyte chemoattractant protein-1. Identification of two functional domains. , 1994, Journal of immunology.

[63]  K. Matsushima,et al.  Prevention of endotoxemia-induced acute respiratory distress syndrome-like lung injury in rabbits by a monoclonal antibody to IL-8. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[64]  D. Blanchard,et al.  Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8. , 1990, Journal of immunology.

[65]  B. Dewald,et al.  A novel neutrophil-activating factor produced by human mononuclear phagocytes , 1988, The Journal of experimental medicine.

[66]  D. Remick,et al.  Regulation of interleukin 8 gene expression by oxidant stress. , 1993, The Journal of biological chemistry.

[67]  S. Kunkel,et al.  Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production. , 1996, Journal of immunology.

[68]  R. Strieter,et al.  Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. , 1996, American journal of respiratory and critical care medicine.

[69]  R. Koehler,et al.  Monoclonal Leukocyte Antibody Does Not Decrease the Injury of Transient Focal Cerebral Ischemia in Cats , 1992, Stroke.

[70]  D. Taub,et al.  Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. , 1995, The Journal of clinical investigation.

[71]  M. Burdick,et al.  Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. , 1996, The Journal of clinical investigation.

[72]  R. Korthuis,et al.  Leukocyte depletion attenuates vascular injury in postischemic skeletal muscle. , 1988, The American journal of physiology.

[73]  H. Folkesson,et al.  Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. , 1995, The Journal of clinical investigation.

[74]  M. Baggiolini,et al.  Mechanism of neutrophil activation by NAF, a novel monocyte‐derived peptide agonist , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[75]  B. Dewald,et al.  Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin , 1996, The Journal of experimental medicine.

[76]  D. Salant,et al.  RANTES and Monocyte Chemoattractant Protein–1 (MCP-1) Play an Important Role in the Inflammatory Phase of Crescentic Nephritis, but Only MCP-1 Is Involved in Crescent Formation and Interstitial Fibrosis , 1997, The Journal of experimental medicine.

[77]  M. Sloan Thrombolysis and stroke. Past and future. , 1987, Archives of neurology.

[78]  K. Matsushima,et al.  Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[79]  C. Valeri,et al.  Pathophysiology of ischaemia reperfusion injury: Central role of the neutrophil , 1991, The British journal of surgery.

[80]  J. Van Damme,et al.  Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. , 1989, The American journal of pathology.

[81]  K. Matsushima,et al.  Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor , 1994, Infection and immunity.

[82]  K. Matsushima,et al.  Prevention of endotoxin shock by an antibody against leukocyte integrin beta 2 through inhibiting production and action of TNF. , 1995, International immunology.

[83]  B Dewald,et al.  Human chemokines: an update. , 1997, Annual review of immunology.

[84]  E. Appella,et al.  The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. , 1989, Science.

[85]  K. Matsushima,et al.  Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8 , 1993, Nature.

[86]  E. Bauer,et al.  Melanoma growth-stimulatory activity/GRO decreases collagen expression by human fibroblasts. Regulation by C-X-C but not C-C cytokines. , 1993, The Journal of biological chemistry.

[87]  Obin,et al.  Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. , 1989, Science.

[88]  K. Matsushima,et al.  Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1- and NF-kappaB-binding sites of the interleukin-8 gene , 1997, Journal of virology.

[89]  The adult respiratory distress syndrome. Definition and prognosis. , 1990, Clinics in chest medicine.

[90]  N. Mukaida,et al.  Enhancement human cytomegalovirus replication in a human lung fibroblast cell line by interleukin-8 , 1994, Journal of virology.

[91]  E. Appella,et al.  Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor , 1988, The Journal of experimental medicine.

[92]  S. Davis Tissue rescue therapy for acute ischaemic stroke , 1995, Journal of Clinical Neuroscience.

[93]  L. Koenderman,et al.  Modulation and induction of eosinophil chemotaxis by granulocyte- macrophage colony-stimulating factor and interleukin-3 , 1991 .

[94]  M. Kaliner,et al.  Neutrophil attractant/activation protein-1 (NAP-1) causes human basophil histamine release. , 1989, Immunology letters.

[95]  J. Norgauer,et al.  Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells. , 1996, Journal of immunology.

[96]  L. Ernster Biochemistry of reoxygenation injury , 1988, Critical care medicine.

[97]  M. Raffeld,et al.  Neutrophil recruitment by intradermally injected neutrophil attractant/activation protein-1. , 1991, The Journal of investigative dermatology.

[98]  G. Opdenakker,et al.  Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family , 1992, The Journal of experimental medicine.

[99]  M. Baggiolini,et al.  Monocyte chemotactic proteins MCP‐1, MCP‐2, and MCP‐3 are major attractants for human CD4+ and CD8+ T lymphocytes , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[100]  D. Danilenko,et al.  Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. , 1994, The Journal of clinical investigation.

[101]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[102]  G. Bulkley,et al.  The primary localization of free radical generation after anoxia/reoxygenation in isolated endothelial cells. , 1987, Surgery.

[103]  K. Matsushima,et al.  Prevention of proteinuria by the administration of anti-interleukin 8 antibody in experimental acute immune complex-induced glomerulonephritis , 1994, The Journal of experimental medicine.

[104]  B. Sykes,et al.  Neutrophil activation by monomeric interleukin-8 , 1994 .

[105]  S. Coughlin,et al.  Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[106]  K. Matsushima,et al.  Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. , 1996, Kidney international.

[107]  Y. Shiga,et al.  Neutrophil as a mediator of ischemic edema formation in the brain , 1991, Neuroscience Letters.

[108]  M. Baggiolini,et al.  Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. , 1987, Biochemical and biophysical research communications.

[109]  N. Mukaida,et al.  Recombinant human growth-regulated oncogene-alpha induces T lymphocyte chemotaxis. A process regulated via IL-8 receptors by IFN-gamma, TNF-alpha, IL-4, IL-10, and IL-13. , 1995, Journal of immunology.

[110]  J. Schifferli,et al.  NAP-1/IL-8 induces up-regulation of CR1 receptors in human neutrophil leukocytes. , 1990, Biochemical and biophysical research communications.

[111]  T. Standiford,et al.  Macrophage inflammatory protein-1 alpha mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia. , 1995, Journal of immunology.

[112]  J. Schröder,et al.  The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate , 1989, The Journal of experimental medicine.

[113]  R. Strieter,et al.  Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.

[114]  J. Minckler Pathology of the nervous system , 1968 .

[115]  A. Siegbahn,et al.  Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor. , 1996, Thrombosis research.

[116]  Cameron Js Glomerulonephritis: current problems and understanding. , 1982 .

[117]  D. Remick,et al.  Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood. , 1992, The Journal of clinical investigation.

[118]  M. Yamada,et al.  Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). , 1989, Biochemical and biophysical research communications.

[119]  D. Graves,et al.  Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. , 1992, Journal of immunology.

[120]  T L Petty,et al.  Acute respiratory distress in adults. , 1967, Lancet.

[121]  P. Weinstein,et al.  Attenuation of postischemic brain hypoperfusion and reperfusion injury by the cyclooxygenase-lipoxygenase inhibitor BW755C. , 1995, Journal of neurosurgery.

[122]  B. Gesser,et al.  The delayed-type hypersensitivity reaction is dependent on IL-8. Inhibition of a tuberculin skin reaction by an anti-IL-8 monoclonal antibody. , 1995, Journal of immunology.

[123]  K. Kawasaki,et al.  Depletion of CD8 positive cells in nephrotoxic serum nephritis of WKY rats. , 1992, Kidney international.

[124]  R. Bronson,et al.  Lack of Evidence for Neutrophil Participation during Infarct Formation Following Focal Cerebral Ischemia in the Rat , 1996, Experimental Neurology.

[125]  A. Cerami,et al.  Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression. , 1993, Journal of immunology.